♥
ISIN : INE795B01031
BSE : 506373
Face Value : 2
Industry : Chemicals
EPS :
EPS (TTM) : 0.00
Price to Earning (P/E) :
Book Value : -3.43
Price to Bookvalue (P/B) : -45.90
Dividend Yield : 0 %
Return on Equity (ROE) : %
Return on Capital Employed (ROCE) : -144.16 %
CITURGIA BIOCHEMICALS LTD
ISIN : INE795B01031
BSE : 506373
Face Value : 2
Industry : Chemicals
EPS :
EPS (TTM) : 0.00
Price to Earning (P/E) :
Book Value : -3.43
Price to Bookvalue (P/B) : -45.90
Dividend Yield : 0 %
Return on Equity (ROE) : %
Return on Capital Employed (ROCE) : -144.16 %
CITURGIA BIOCHEMICALS share price(02-Apr-2026) | |
|---|---|
| Open / Close | 157.45 - 157.45 0 % |
| Low / High | 157.45 - 157.45 0 % |
| Trade Volume | 2 |
| 52 Week Low / High | 47.4 - 212 347.3 % |
-
YOU MAY ALSO LIKE
- Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Stock market course tutorial
Stock Market Investment Course explained in simple words. - Share Market basics for beginners
Share Market jargons in simple terms - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
CONSOLIDATED QUARTERLY RESULT FOR CITURGIA BIOCHEMICALS LTD
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Total Expenditure | 0.53 | 0.3 | 0.44 | 0.45 | 0.87 | 0.39 | 0.86 | 0.5 | 0.75 | 0.38 |
| Operating Profit | -0.53 | -0.3 | -0.44 | -0.45 | -0.87 | -0.39 | -0.86 | -0.5 | -0.75 | -0.38 |
| PBDT | -0.53 | -0.3 | -0.44 | -0.45 | -0.87 | -0.39 | -0.86 | -0.5 | -0.75 | -0.38 |
| Depreciation | 0.57 | 0.52 | 0.6 | 0.57 | 0.57 | 0.51 | 0.6 | 0.57 | 0.57 | 0.52 |
| Profit Before Tax | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Profit After Tax | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Net Profit | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Equity Capital | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 |
| Face Value (IN RS) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Calculated EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
STANDALONE QUARTERLY RESULT FOR CITURGIA BIOCHEMICALS LTD
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Total Expenditure | 0.53 | 0.3 | 0.44 | 0.45 | 0.87 | 0.39 | 0.86 | 0.5 | 0.75 | 0.38 |
| Operating Profit | -0.53 | -0.3 | -0.44 | -0.45 | -0.87 | -0.39 | -0.86 | -0.5 | -0.75 | -0.38 |
| PBDT | -0.53 | -0.3 | -0.44 | -0.45 | -0.87 | -0.39 | -0.86 | -0.5 | -0.75 | -0.38 |
| Depreciation | 0.57 | 0.52 | 0.6 | 0.57 | 0.57 | 0.51 | 0.6 | 0.57 | 0.57 | 0.52 |
| Profit Before Tax | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Profit After Tax | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Net Profit | -1.1 | -0.82 | -1.04 | -1.02 | -1.44 | -0.9 | -1.46 | -1.07 | -1.32 | -0.9 |
| Equity Capital | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 | 264.19 |
| Face Value (IN RS) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Calculated EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
CONSOLIDATED ANNUAL RESULT FOR CITURGIA BIOCHEMICALS LTD
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Total Expenditure | 1.78 | 2.11 | 2.5 |
| Operating Profit | -1.78 | -2.11 | -2.5 |
| PBDT | -1.78 | -2.11 | -2.5 |
| Depreciation | 2.26 | 2.26 | 2.26 |
| Profit Before Tax | -4.04 | -4.37 | -4.76 |
| Profit After Tax | -4.04 | -4.37 | -4.76 |
| Net Profit | -4.04 | -4.37 | -4.76 |
| Equity Capital | 264.19 | 264.19 | 264.19 |
| Face Value (IN RS) | 2 | 2 | 2 |
| Calculated EPS | -0.03 | -0.03 | -0.04 |
STANDALONE ANNUAL RESULT FOR CITURGIA BIOCHEMICALS LTD
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Total Expenditure | 1.78 | 2.11 | 2.5 |
| Operating Profit | -1.78 | -2.11 | -2.5 |
| PBDT | -1.78 | -2.11 | -2.5 |
| Depreciation | 2.26 | 2.26 | 2.26 |
| Profit Before Tax | -4.04 | -4.37 | -4.76 |
| Profit After Tax | -4.04 | -4.37 | -4.76 |
| Net Profit | -4.04 | -4.37 | -4.76 |
| Equity Capital | 264.19 | 264.19 | 264.19 |
| Face Value (IN RS) | 2 | 2 | 2 |
| Calculated EPS | -0.03 | -0.03 | -0.04 |
CONSOLIDATED PROFIT / LOSS FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Opening Raw Materials | 0 | 0 | 1.23 Lk | 0 |
| Closing Raw Materials | 0 | 0 | 1.23 Lk | 0 |
| Employee Cost | 13.75 Lk | 15.91 Lk | 16.2 Lk | 16.9 Lk |
| Salaries, Wages & Bonus | 13.75 Lk | 15.91 Lk | 16.2 Lk | 16.9 Lk |
| General and Administration Expenses | 23.55 Lk | 1.6 Lk | 4.36 Lk | 7.74 Lk |
| Rent , Rates & Taxes | 26,426 | 0 | 0 | 0 |
| Professional and legal fees | 22.88 Lk | 1.35 Lk | 4.11 Lk | 7.09 Lk |
| Selling and Distribution Expenses | 0 | 8,560 | 0 | 0 |
| Advertisement & Sales Promotion | 0 | 8,560 | 0 | 0 |
| Miscellaneous Expenses | 0 | 25,254 | 48,956 | 35,108 |
| Total Expenditure | 37.3 Lk | 17.85 Lk | 21.05 Lk | 24.99 Lk |
| Operating Profit | -37.3 Lk | -17.85 Lk | -21.05 Lk | -24.99 Lk |
| Interest | 3,033.46 | 76.7 | 955.4 | 670.36 |
| PBDT | -37.33 Lk | -17.85 Lk | -21.06 Lk | -25 Lk |
| Depreciation | 23.87 Lk | 22.56 Lk | 22.56 Lk | 22.56 Lk |
| Profit Before Taxation & Exceptional Items | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit Before Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit After Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Consolidated Net Profit | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit Balance B/F | -33.63 Cr | -34.25 Cr | -34.65 Cr | -35.09 Cr |
| Appropriations | -34.25 Cr | -34.65 Cr | -35.09 Cr | -35.56 Cr |
| Earnings Per Share | -0.23 | -0.15 | -0.17 | -0.18 |
| Adjusted EPS | -0.23 | -0.15 | -0.17 | -0.18 |
STANDALONE PROFIT / LOSS FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Opening Raw Materials | 0 | 0 | 1.23 Lk | 0 |
| Closing Raw Materials | 0 | 0 | 1.23 Lk | 0 |
| Employee Cost | 13.75 Lk | 15.91 Lk | 16.2 Lk | 16.9 Lk |
| Salaries, Wages & Bonus | 13.75 Lk | 15.91 Lk | 16.2 Lk | 16.9 Lk |
| General and Administration Expenses | 23.55 Lk | 1.6 Lk | 4.36 Lk | 7.74 Lk |
| Rent , Rates & Taxes | 26,426 | 0 | 0 | 0 |
| Professional and legal fees | 22.88 Lk | 1.35 Lk | 4.11 Lk | 7.09 Lk |
| Selling and Distribution Expenses | 0 | 8,560 | 0 | 0 |
| Advertisement & Sales Promotion | 0 | 8,560 | 0 | 0 |
| Miscellaneous Expenses | 0 | 25,254 | 48,956 | 35,108 |
| Total Expenditure | 37.3 Lk | 17.85 Lk | 21.05 Lk | 24.99 Lk |
| Operating Profit | -37.3 Lk | -17.85 Lk | -21.05 Lk | -24.99 Lk |
| Interest | 3,033.46 | 76.7 | 955.4 | 670.36 |
| PBDT | -37.33 Lk | -17.85 Lk | -21.06 Lk | -25 Lk |
| Depreciation | 23.87 Lk | 22.56 Lk | 22.56 Lk | 22.56 Lk |
| Profit Before Taxation & Exceptional Items | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit Before Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit After Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Consolidated Net Profit | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Profit Balance B/F | -33.63 Cr | -34.25 Cr | -34.65 Cr | -35.09 Cr |
| Appropriations | -34.25 Cr | -34.65 Cr | -35.09 Cr | -35.56 Cr |
| Earnings Per Share | -0.23 | -0.15 | -0.17 | -0.18 |
| Adjusted EPS | -0.23 | -0.15 | -0.17 | -0.18 |
CONSOLIDATED CASH FLOW FOR CITURGIA BIOCHEMICALS LTD
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Adjustment | 23.87 Lk | 22.56 Lk | 22.56 Lk | 22.56 Lk |
| Changes In working Capital | 22.52 Lk | 15 Lk | 14.3 Lk | 10.83 Lk |
| Cash Flow after changes in Working Capital | -14.81 Lk | -2.85 Lk | -6.76 Lk | -14.17 Lk |
| Cash Flow from Operating Activities | -14.81 Lk | -2.85 Lk | -6.76 Lk | -14.17 Lk |
| Cash Flow from Investing Activities | 14.6 Lk | 1.4 Lk | 3.6 Lk | -5 Lk |
| Cash Flow from Financing Activitie | 1.2 Lk | 0 | 5.6 Lk | 21.8 Lk |
| Net Cash Inflow / Outflow | 99,242 | -1.45 Lk | 2.44 Lk | 2.63 Lk |
| Opening Cash & Cash Equivalents | 5.86 Lk | 6.85 Lk | 5.4 Lk | 7.84 Lk |
| Closing Cash & Cash Equivalent | 6.85 Lk | 5.4 Lk | 7.84 Lk | 10.47 Lk |
STANDALONE CASH FLOW FOR CITURGIA BIOCHEMICALS LTD
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -61.2 Lk | -40.41 Lk | -43.62 Lk | -47.56 Lk |
| Adjustment | 23.87 Lk | 22.56 Lk | 22.56 Lk | 22.56 Lk |
| Changes In working Capital | 22.52 Lk | 15 Lk | 14.3 Lk | 10.83 Lk |
| Cash Flow after changes in Working Capital | -14.81 Lk | -2.85 Lk | -6.76 Lk | -14.17 Lk |
| Cash Flow from Operating Activities | -14.81 Lk | -2.85 Lk | -6.76 Lk | -14.17 Lk |
| Cash Flow from Investing Activities | 14.6 Lk | 1.4 Lk | 3.6 Lk | -5 Lk |
| Cash Flow from Financing Activitie | 1.2 Lk | 0 | 5.6 Lk | 21.8 Lk |
| Net Cash Inflow / Outflow | 99,242 | -1.45 Lk | 2.44 Lk | 2.63 Lk |
| Opening Cash & Cash Equivalents | 5.86 Lk | 6.85 Lk | 5.4 Lk | 7.84 Lk |
| Closing Cash & Cash Equivalent | 6.85 Lk | 5.4 Lk | 7.84 Lk | 10.47 Lk |
CONSOLIDATED BALANCE SHEET FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Equity - Authorised | 27 Cr | 27 Cr | 27 Cr | 27 Cr |
| Equity - Issued | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Equity Paid Up | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | -34.17 Cr | -34.58 Cr | -35.01 Cr | -35.49 Cr |
| Capital Reserves | 4.2 Lk | 4.2 Lk | 4.2 Lk | 4.2 Lk |
| Profit & Loss Account Balance | -34.25 Cr | -34.65 Cr | -35.09 Cr | -35.56 Cr |
| Reserve excluding Revaluation Reserve | -34.17 Cr | -34.58 Cr | -35.01 Cr | -35.49 Cr |
| Shareholder's Funds | -5.25 Cr | -5.66 Cr | -6.09 Cr | -6.57 Cr |
| Unsecured Loans | 6.46 Cr | 6.46 Cr | 6.52 Cr | 6.74 Cr |
| Loans - Others | 6.46 Cr | 6.46 Cr | 6.52 Cr | 6.74 Cr |
| Deferred Tax Assets / Liabilities | 1.71 Cr | 0 | 1.71 Cr | 1.71 Cr |
| Deferred Tax Liability | 1.71 Cr | 0 | 1.71 Cr | 1.71 Cr |
| Other Long Term Liabilities | 11.73 Lk | 0 | 11.73 Lk | 11.73 Lk |
| Total Non-Current Liabilities | 8.29 Cr | 6.46 Cr | 8.35 Cr | 8.56 Cr |
| Trade Payables | 3.63 Cr | 3.63 Cr | 3.63 Cr | 3.63 Cr |
| Sundry Creditors | 3.63 Cr | 3.63 Cr | 3.63 Cr | 3.63 Cr |
| Other Current Liabilities | 4.39 Cr | 6.36 Cr | 4.76 Cr | 4.87 Cr |
| Short Term Borrowings | 3.4 Lk | 3.4 Lk | 3.4 Lk | 3.4 Lk |
| Short Term Provisions | 51.01 Lk | 51.01 Lk | 51.01 Lk | 51.01 Lk |
| Provision for Tax | 51.01 Lk | 51.01 Lk | 51.01 Lk | 51.01 Lk |
| Total Current Liabilities | 8.56 Cr | 10.54 Cr | 8.94 Cr | 9.05 Cr |
| Total Liabilities | 11.6 Cr | 11.34 Cr | 11.19 Cr | 11.04 Cr |
| Gross Block | 6.42 Cr | 1.65 Cr | 6.42 Cr | 6.42 Cr |
| Less: Accumulated Depreciation | 4.9 Cr | 35.54 Lk | 5.35 Cr | 5.58 Cr |
| Net Block | 1.52 Cr | 1.3 Cr | 1.07 Cr | 84.68 Lk |
| Non Current Investments | 2,000 | 2,000 | 2,000 | 2,000 |
| Long Term Investment | 2,000 | 2,000 | 2,000 | 2,000 |
| Unquoted | 2,000 | 2,000 | 2,000 | 2,000 |
| Long Term Loans & Advances | 1.81 Cr | 1.79 Cr | 1.84 Cr | 1.89 Cr |
| Total Non-Current Assets | 3.33 Cr | 3.09 Cr | 2.92 Cr | 2.74 Cr |
| Unquoted | 2,000 | 2,000 | 2,000 | 2,000 |
| Inventories | 8.07 Cr | 8.07 Cr | 8.07 Cr | 8.07 Cr |
| Raw Materials | 1.23 Lk | 1.23 Lk | 1.23 Lk | 1.23 Lk |
| Work-in Progress | 8.03 Cr | 8.03 Cr | 8.03 Cr | 8.03 Cr |
| Finished Goods | 1,495 | 1,495 | 1,495 | 1,495 |
| Stores and Spare | 2.74 Lk | 2.74 Lk | 2.74 Lk | 2.74 Lk |
| Cash and Bank | 6.85 Lk | 5.4 Lk | 7.84 Lk | 10.47 Lk |
| Cash in hand | 2,328.38 | 57,074.1 | 2.39 Lk | 5.02 Lk |
| Balances at Bank | 6.82 Lk | 4.83 Lk | 5.45 Lk | 5.45 Lk |
| Other Current Assets | 10.08 Lk | 10.08 Lk | 10.08 Lk | 10.08 Lk |
| Short Term Loans and Advances | 3.02 Lk | 3.02 Lk | 3.02 Lk | 3.02 Lk |
| Total Current Assets | 8.27 Cr | 8.25 Cr | 8.28 Cr | 8.3 Cr |
| Net Current Assets (Including Current Investments) | -29.55 Lk | -2.29 Cr | -66.26 Lk | -74.45 Lk |
| Total Assets | 11.6 Cr | 11.34 Cr | 11.19 Cr | 11.04 Cr |
| Total Debt | 6.5 Cr | 6.5 Cr | 6.55 Cr | 6.77 Cr |
| Book Value | 0 | 0 | 0 | -3.43 |
| Adjusted Book Value | -2.93 | -3.09 | -3.25 | -3.43 |
STANDALONE BALANCE SHEET FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Equity - Authorised | 27 Cr | 27 Cr | 27 Cr | 27 Cr |
| Equity - Issued | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Equity Paid Up | 26.42 Cr | 26.42 Cr | 26.42 Cr | 26.42 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | -34.17 Cr | -34.58 Cr | -35.01 Cr | -35.49 Cr |
| Capital Reserves | 4.2 Lk | 4.2 Lk | 4.2 Lk | 4.2 Lk |
| Profit & Loss Account Balance | -34.25 Cr | -34.65 Cr | -35.09 Cr | -35.56 Cr |
| Reserve excluding Revaluation Reserve | -34.17 Cr | -34.58 Cr | -35.01 Cr | -35.49 Cr |
| Shareholder's Funds | -5.25 Cr | -5.66 Cr | -6.09 Cr | -6.57 Cr |
| Unsecured Loans | 6.46 Cr | 6.46 Cr | 6.52 Cr | 6.74 Cr |
| Loans - Others | 6.46 Cr | 6.46 Cr | 6.52 Cr | 6.74 Cr |
| Deferred Tax Assets / Liabilities | 1.71 Cr | 0 | 1.71 Cr | 1.71 Cr |
| Deferred Tax Liability | 1.71 Cr | 0 | 1.71 Cr | 1.71 Cr |
| Other Long Term Liabilities | 11.73 Lk | 0 | 11.73 Lk | 11.73 Lk |
| Total Non-Current Liabilities | 8.29 Cr | 6.46 Cr | 8.35 Cr | 8.56 Cr |
| Trade Payables | 3.63 Cr | 3.63 Cr | 3.63 Cr | 3.63 Cr |
| Sundry Creditors | 3.63 Cr | 3.63 Cr | 3.63 Cr | 3.63 Cr |
| Other Current Liabilities | 4.39 Cr | 6.36 Cr | 4.76 Cr | 4.87 Cr |
| Short Term Borrowings | 3.4 Lk | 3.4 Lk | 3.4 Lk | 3.4 Lk |
| Short Term Provisions | 51.01 Lk | 51.01 Lk | 51.01 Lk | 51.01 Lk |
| Provision for Tax | 51.01 Lk | 51.01 Lk | 51.01 Lk | 51.01 Lk |
| Total Current Liabilities | 8.56 Cr | 10.54 Cr | 8.94 Cr | 9.05 Cr |
| Total Liabilities | 11.6 Cr | 11.34 Cr | 11.19 Cr | 11.04 Cr |
| Gross Block | 6.42 Cr | 1.65 Cr | 6.42 Cr | 6.42 Cr |
| Less: Accumulated Depreciation | 4.9 Cr | 35.54 Lk | 5.35 Cr | 5.58 Cr |
| Net Block | 1.52 Cr | 1.3 Cr | 1.07 Cr | 84.68 Lk |
| Non Current Investments | 2,000 | 2,000 | 2,000 | 2,000 |
| Long Term Investment | 2,000 | 2,000 | 2,000 | 2,000 |
| Unquoted | 2,000 | 2,000 | 2,000 | 2,000 |
| Long Term Loans & Advances | 1.81 Cr | 1.79 Cr | 1.84 Cr | 1.89 Cr |
| Total Non-Current Assets | 3.33 Cr | 3.09 Cr | 2.92 Cr | 2.74 Cr |
| Unquoted | 2,000 | 2,000 | 2,000 | 2,000 |
| Inventories | 8.07 Cr | 8.07 Cr | 8.07 Cr | 8.07 Cr |
| Raw Materials | 1.23 Lk | 1.23 Lk | 1.23 Lk | 1.23 Lk |
| Work-in Progress | 8.03 Cr | 8.03 Cr | 8.03 Cr | 8.03 Cr |
| Finished Goods | 1,495 | 1,495 | 1,495 | 1,495 |
| Stores and Spare | 2.74 Lk | 2.74 Lk | 2.74 Lk | 2.74 Lk |
| Cash and Bank | 6.85 Lk | 5.4 Lk | 7.84 Lk | 10.47 Lk |
| Cash in hand | 2,328.38 | 57,074.1 | 2.39 Lk | 5.02 Lk |
| Balances at Bank | 6.82 Lk | 4.83 Lk | 5.45 Lk | 5.45 Lk |
| Other Current Assets | 10.08 Lk | 10.08 Lk | 10.08 Lk | 10.08 Lk |
| Short Term Loans and Advances | 3.02 Lk | 3.02 Lk | 3.02 Lk | 3.02 Lk |
| Total Current Assets | 8.27 Cr | 8.25 Cr | 8.28 Cr | 8.3 Cr |
| Net Current Assets (Including Current Investments) | -29.55 Lk | -2.29 Cr | -66.26 Lk | -74.45 Lk |
| Total Assets | 11.6 Cr | 11.34 Cr | 11.19 Cr | 11.04 Cr |
| Total Debt | 6.5 Cr | 6.5 Cr | 6.55 Cr | 6.77 Cr |
| Book Value | 0 | 0 | 0 | -3.43 |
| Adjusted Book Value | -2.93 | -3.09 | -3.25 | -3.43 |
FINANCIAL RATIOS (CONSOLIDATED) FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -0.23 | -0.15 | -0.17 | -0.18 |
| CEPS(Rs) | -0.14 | -0.07 | -0.08 | -0.09 |
| Book NAV/Share(Rs) | -2.93 | -3.09 | -3.25 | -3.43 |
| Margin Ratios | ||||
| Performance Ratios | ||||
| ROA(%) | -5.19 | -3.52 | -3.86 | -4.28 |
| ROCE(%) | -39.64 | -38.82 | -67.22 | -144.16 |
| Efficiency Ratios | ||||
| Valuation Parameters | ||||
| EV/Core EBITDA(x) | -88.07 | -184.1 | -156.27 | -132.4 |
| EV/EBIT(x) | -53.7 | -81.31 | -75.42 | -69.57 |
| EV/CE(x) | 2.83 | 2.9 | 2.94 | 164.54 |
| Growth Ratio | ||||
| Core EBITDA Growth(%) | -216.68 | 52.14 | -17.92 | -18.72 |
| EBIT Growth(%) | -55.04 | 33.93 | -7.92 | -9.03 |
| PAT Growth(%) | -54.45 | 33.96 | -7.94 | -9.03 |
| EPS Growth(%) | -54.45 | 33.96 | -7.91 | -9.03 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | -0.84 | -0.8 | -0.76 | -0.75 |
| Current Ratio(x) | 0.97 | 0.78 | 0.93 | 0.92 |
| Quick Ratio(x) | 0.02 | 0.02 | 0.02 | 0.03 |
| Interest Cover(x) | -2016.36 | 0 | -4564.75 | -7093.47 |
FINANCIAL RATIOS (STANDALONE) FOR CITURGIA BIOCHEMICALS LTD
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -0.23 | -0.15 | -0.17 | -0.18 |
| CEPS(Rs) | -0.14 | -0.07 | -0.08 | -0.09 |
| Book NAV/Share(Rs) | -2.93 | -3.09 | -3.25 | -3.43 |
| Margin Ratios | ||||
| Performance Ratios | ||||
| ROA(%) | -5.19 | -3.52 | -3.86 | -4.28 |
| ROCE(%) | -39.64 | -38.82 | -67.22 | -144.16 |
| Efficiency Ratios | ||||
| Valuation Parameters | ||||
| EV/Core EBITDA(x) | -88.07 | -184.1 | -156.27 | -132.4 |
| EV/EBIT(x) | -53.7 | -81.31 | -75.42 | -69.57 |
| EV/CE(x) | 2.83 | 2.9 | 2.94 | 164.54 |
| Growth Ratio | ||||
| Core EBITDA Growth(%) | -216.68 | 52.14 | -17.92 | -18.72 |
| EBIT Growth(%) | -55.04 | 33.93 | -7.92 | -9.03 |
| PAT Growth(%) | -54.45 | 33.96 | -7.94 | -9.03 |
| EPS Growth(%) | -54.45 | 33.96 | -7.91 | -9.03 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | -0.84 | -0.8 | -0.76 | -0.75 |
| Current Ratio(x) | 0.97 | 0.78 | 0.93 | 0.92 |
| Quick Ratio(x) | 0.02 | 0.02 | 0.02 | 0.03 |
| Interest Cover(x) | -2016.36 | 0 | -4564.75 | -7093.47 |
SHARE HOLDING PATTERN FOR CITURGIA BIOCHEMICALS LTD
| Date | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 0.04 | 0.04 | 0.04 | 99.67 | 99.67 | 99.67 | 0.04 | 0.04 | 0.04 | 0.04 |
| FII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public % | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
PEER COMPARISON FOR CITURGIA BIOCHEMICALS LTD
CORPORATE ACTIONS FOR CITURGIA BIOCHEMICALS
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 05-Sep-2024 | Book Closure - A.G.M. | 26-Sep-2024 29-Sep-2024 |
| BSE 05-Sep-2024 | AGM - A.G.M. | 29-Sep-2024 29-Sep-2024 |
| BSE 28-Aug-2024 | Board Meeting - A.G.M. | 31-Aug-2024 |
| BSE 07-Aug-2024 | Board Meeting - Quarterly Results | 14-Aug-2024 |
| BSE 16-May-2024 | Board Meeting - Quarterly Results | 16-May-2024 |
| BSE 31-Jan-2024 | Board Meeting - Quarterly Results | 14-Feb-2024 |
| BSE 01-Sep-2023 | Book Closure - A.G.M. | 25-Sep-2023 29-Sep-2023 |
| BSE 01-Sep-2023 | AGM - A.G.M. | 29-Sep-2023 29-Sep-2023 |
| BSE 04-Aug-2023 | Board Meeting - Quarterly Results | 14-Aug-2023 |
| BSE 22-May-2023 | Board Meeting - Audited Results & Quarterly Results | 30-May-2023 |
| BSE 08-Feb-2023 | Board Meeting - Quarterly Results | 14-Feb-2023 |
| BSE 25-Nov-2022 | Board Meeting - Inter alia, to consider and approve the proposal of withdrawal of application made for reclassification from ?Promoter Group? category to ?Public? category shareholders in accordance with Regulations 30 and 31A SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. | 28-Nov-2022 |
| BSE 07-Nov-2022 | Board Meeting - Quarterly Results | 14-Nov-2022 |
| BSE 19-Sep-2022 | Book Closure - A.G.M. | 24-Sep-2022 28-Sep-2022 |
| BSE 19-Sep-2022 | AGM - A.G.M. | 28-Sep-2022 28-Sep-2022 |
| BSE 01-Sep-2022 | Board Meeting - A.G.M. | 03-Sep-2022 |
| BSE 11-Aug-2022 | Board Meeting - Quarterly Results | 12-Aug-2022 |
| BSE 31-May-2022 | Board Meeting - Quarterly Results (Revised) | 10-Jun-2022 |
| BSE 23-May-2022 | Board Meeting - Quarterly Results | 30-May-2022 |
| BSE 07-Feb-2022 | Board Meeting - Quarterly Results | 11-Feb-2022 |
| BSE 11-Nov-2021 | Board Meeting - Quarterly Results | 15-Nov-2021 |
| BSE 13-Sep-2021 | Book Closure - A.G.M. | 26-Sep-2021 29-Sep-2021 |
| BSE 13-Sep-2021 | AGM - Exchange Received Time 06-09-2021 15:23:44 Exchange Disseminated Time 06-09-2021 15:23:47 Time Taken 00:00:03 Intimation of Book Closure for the Purpose of Annual General Meeting | 30-Sep-2021 29-Sep-2021 |
| BSE 02-Sep-2021 | Board Meeting - A.G.M. | 06-Sep-2021 |
CORPORATE ANNOUNCEMENTS FOR CITURGIA BIOCHEMICALS
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 03-Oct-2024 | Intimation FILE | Closure of Trading Window CLOSURE OF TRADING WINDOW |
| BSE 01-Oct-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM OUTCOME OF AGM |
| BSE 09-Sep-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. ANNUAL REPORT 2023-2024 |
| BSE 31-Aug-2024 | General Announcements FILE | Intimation Of Book Closure intimation of Book Closure |
| BSE 31-Aug-2024 | Outcome FILE | Board Meeting Outcome for OUTCOME OF BOARD MEETING Outcome of Board Meeting dated 31.08.2024 |
| BSE 28-Aug-2024 | Intimation FILE | Board Meeting Intimation for Consider And Approve Intimation Of Annual General Meeting CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2024 inter alia to consider and approve Intimation of Annual General Meeting |
| BSE 28-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Resignation of company secretary secretary / compliance officer |
| BSE 21-Aug-2024 | Delay in Financial Results FILE | Results-Delay in Financial Results Unaudited Financial Result for the quarter ended on 30.06.2024 |
| BSE 07-Aug-2024 | Intimation FILE | Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended On 30Th June 2024. CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended on 30th June 2024. |
| BSE 01-Jul-2024 | Intimation FILE | Closure of Trading Window CLOSURE OF TRADING WINDOW |
| BSE 03-Jun-2024 | General Announcements FILE | Appointment of Company Secretary and Compliance Officer Appointment of company secretary |
| BSE 27-May-2024 | Outcome FILE | Revised Audited Financial Results For The Quarter And Year Ended On 31ST March 2024 Revised Audited Financial Result for the quarter and year ended on 31st March 2024 |
| BSE 22-May-2024 | Outcome FILE | Audited Financial Results For The Quarter And Year Ended On 31ST March 2024. Audited Financial Result For the quarter and year ended on 31st March 2024 |
| BSE 20-May-2024 | Compliance FILE | Compliances-Reg.24(A)-Annual Secretarial Compliance ANNUAL SECRETARIAL REPORT 2023-2024 |
| BSE 16-May-2024 | Intimation FILE | Board Meeting Intimation for Consider And Approve The Audited Financial Results For The Quarter And Year Ended On 31St March 2024. CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31ST MARCH 2024. |
| BSE 14-May-2024 | General Announcements FILE | Disclosure Under Regulation 31(4) Of SEBI Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On 31St March 2024. Disclosure under Regulation 31(4) of sebi Substantial Acquisition of share of takeover |
| BSE 08-May-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Enclosed herewith Compliance Certificate for the Quarter ended 31.03.2024 |
| BSE 08-May-2024 | Compliance FILE | Enclosed Herewith Compliance Certificate For The Quarter Ended 31.03.2024 Enclosed herewith Compliance Certificate for the Quarter ended 31.03.2024 |
| BSE 07-May-2024 | Compliance FILE | Enclosed Herewith Compliance Certificate For The Year Ended 31.03.2024 Enclosed herewith Compliance Certificate for the year ended 31.03.2024 |
| BSE 07-May-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM REVISED OUTCOME OF AGM MENTIONING THE TIME OF CONCLUSION OF AGM |
| BSE 02-Apr-2024 | Intimation FILE | Closure of Trading Window Closure of trading window |
| BSE 14-Feb-2024 | Outcome FILE | Unaudited Financial Results For Quarter Ended On 31St December 2023 Unaudited Financial Result For the Quarter ended on 31st December 2023 |
| BSE 31-Jan-2024 | Intimation FILE | Board Meeting Intimation for Consider And Approve Unaudited Financial Results For The Quarter Ended On 31St December 2023. CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited Financial Results for the Quarter ended on 31st December 2023. |
| BSE 03-Jan-2024 | Delay in Financial Results FILE | Results-Delay in Financial Results UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 30.09.2023 |
| BSE 03-Jan-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. Annual report 2022-2023 |
| BSE 29-Dec-2023 | Delay in Financial Results FILE | Results-Delay in Financial Results AUDITED FINANCIAL RESULT FOR THE HALF YEAR AND YEAR ENDED 31.03.2023 |
| BSE 29-Dec-2023 | Delay in Financial Results FILE | Results-Delay in Financial Results UNAUDITED FINANCIAl RESULT FOR THE QUARTER ENDED 30.06.2023 REVISED |
| BSE 28-Dec-2023 | Intimation FILE | Closure of Trading Window CLOSURE OF TRADING WINDOW |
| BSE 06-Dec-2023 | Intimation FILE | Board Meeting Intimation for INTIMATION OF BOARD MEETING 30.09.2023 CITURGIA BIOCHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve INTIMATION OF BOARD MEETING 30.09.2023 |
| BSE 21-Oct-2023 | Delay in Financial Results FILE | Results-Delay in Financial Results Unaudited Financial Result For The Quarter Ended 30th June 2023 |
INSIDER TRADING FOR CITURGIA BIOCHEMICALS
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Insider trading details found | |||
BULK BLOCK DEALS FOR CITURGIA BIOCHEMICALS LTD
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| No Bulk Block details found | |||
DIVIDEND BY CITURGIA BIOCHEMICALS LTD
No dividend details found
SPLIT / BONUS BY CITURGIA BIOCHEMICALS LTD
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
